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OBJECTIVES
To study the vulnerability of smooth muscle cells 
(SMCs) in Hutchinson-Gilford Progeria Syndrome 
(HGPS).
WORK PLAN
Hutchinson-Gilford Progeria Syndrome is a rare, 
progressive premature aging disease in children that 
leads to vascular SMCs degeneration and premature 
atherosclerosis.
Death occurs at a mean age of 13 years, usually 
from heart attack or stroke. One of the hallmarks of 
the disease is the dramatic loss of vascular SMCs in 
large arteries. In consequence, the arteries undergo 
vascular remodeling and calcification. So far, it is 
unclear the reason underlining the sensitivity of 
SMCs in the context of the disease.
To clarify the mechanisms behind SMCs loss, it’s 
important to have human HGPSSMC; however, these 
cells are difficult to obtain from Progeria patients. 
Therefore, we derived HGPS induced pluripotent stem 
cells (iPSCs) from skin fibroblasts and then differen- 
tiate them into SMCs.
RESULTS
In this work, iPSCs obtained from HGPS fibro-
blast patients were successfully differentiated 
into HGPS-SMCs. These HGPS-SMCs showed 
impaired maturation and an upregulation of pro-
geria markers when comparing with SMCs differ-
entiated from healthy iPSCs. HGPS-SMCs shared 
similar features observed on progerin-express-
ing cells such as activation of several effectors 
of NOTCH signaling pathway and response to 
farnesyltransferase inhibitors. Therefore we have 
developed a cell model that is suitable for drug 
screening and to study the mechanism of SMC 
loss. This finding opens new opportunities for the 
treatment of HGPS disease and diseases related 
to vascular ageing.
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